MA26602A1 - Composition pharmaceutique de proteines hedgehog, procédé pour sa préparation, et son utilisation pour la libération de ces proteines sur les os et le cartilage. - Google Patents
Composition pharmaceutique de proteines hedgehog, procédé pour sa préparation, et son utilisation pour la libération de ces proteines sur les os et le cartilage.Info
- Publication number
- MA26602A1 MA26602A1 MA25446A MA25446A MA26602A1 MA 26602 A1 MA26602 A1 MA 26602A1 MA 25446 A MA25446 A MA 25446A MA 25446 A MA25446 A MA 25446A MA 26602 A1 MA26602 A1 MA 26602A1
- Authority
- MA
- Morocco
- Prior art keywords
- proteins
- carrier
- hedgehog
- pharmaceutical composition
- hedgehog protein
- Prior art date
Links
- 102000003693 Hedgehog Proteins Human genes 0.000 title abstract 6
- 108090000031 Hedgehog Proteins Proteins 0.000 title abstract 6
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 210000000845 cartilage Anatomy 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 229920000936 Agarose Polymers 0.000 abstract 1
- 230000002378 acidificating effect Effects 0.000 abstract 1
- 230000003111 delayed effect Effects 0.000 abstract 1
- 239000012052 hydrophilic carrier Substances 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 230000003993 interaction Effects 0.000 abstract 1
- 239000000178 monomer Substances 0.000 abstract 1
- 230000007935 neutral effect Effects 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Marine Sciences & Fisheries (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98101893 | 1998-02-04 | ||
| EP98104416 | 1998-03-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA26602A1 true MA26602A1 (fr) | 2004-12-20 |
Family
ID=26149005
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA25446A MA26602A1 (fr) | 1998-02-04 | 1999-02-01 | Composition pharmaceutique de proteines hedgehog, procédé pour sa préparation, et son utilisation pour la libération de ces proteines sur les os et le cartilage. |
Country Status (14)
| Country | Link |
|---|---|
| JP (1) | JP3092706B2 (cs) |
| KR (2) | KR100311565B1 (cs) |
| CN (1) | CN1228994A (cs) |
| AT (1) | ATE331533T1 (cs) |
| AU (1) | AU713568B2 (cs) |
| CA (1) | CA2260423C (cs) |
| CZ (1) | CZ33799A3 (cs) |
| DE (1) | DE69932113T2 (cs) |
| HU (1) | HUP9900251A3 (cs) |
| IL (1) | IL128329A (cs) |
| MA (1) | MA26602A1 (cs) |
| NO (1) | NO990471L (cs) |
| NZ (1) | NZ334065A (cs) |
| SG (1) | SG66504A1 (cs) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW570805B (en) | 1998-09-01 | 2004-01-11 | Hoffmann La Roche | Water-soluble pharmaceutical composition in an ionic complex |
| KR100452752B1 (ko) * | 2000-04-18 | 2004-10-12 | 주식회사 펩트론 | 단백질 함유 서방성 제제를 제조하는 방법 및 그 제제 |
| KR101705323B1 (ko) * | 2010-03-23 | 2017-02-13 | 코웨이 주식회사 | 역삼투막 방식의 정수기 |
| KR102176832B1 (ko) * | 2017-11-29 | 2020-11-10 | 주식회사 파이안바이오테크놀로지 | 헤지호그 단백질 및 생체 적합성 물질을 포함하는 미세 입자 및 이를 포함하는 탈모 예방 또는 치료용 조성물 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5866165A (en) | 1997-01-15 | 1999-02-02 | Orquest, Inc. | Collagen-polysaccharide matrix for bone and cartilage repair |
-
1999
- 1999-01-28 CA CA002260423A patent/CA2260423C/en not_active Expired - Fee Related
- 1999-02-01 NO NO990471A patent/NO990471L/no unknown
- 1999-02-01 CZ CZ99337A patent/CZ33799A3/cs unknown
- 1999-02-01 MA MA25446A patent/MA26602A1/fr unknown
- 1999-02-02 IL IL12832999A patent/IL128329A/xx active IP Right Grant
- 1999-02-03 SG SG1999000333A patent/SG66504A1/en unknown
- 1999-02-03 HU HU9900251A patent/HUP9900251A3/hu unknown
- 1999-02-04 AT AT99101642T patent/ATE331533T1/de not_active IP Right Cessation
- 1999-02-04 KR KR1019990003759A patent/KR100311565B1/ko not_active Expired - Fee Related
- 1999-02-04 DE DE69932113T patent/DE69932113T2/de not_active Expired - Fee Related
- 1999-02-04 JP JP11027836A patent/JP3092706B2/ja not_active Expired - Fee Related
- 1999-02-04 AU AU15426/99A patent/AU713568B2/en not_active Ceased
- 1999-02-04 KR KR1019990003669A patent/KR19990072406A/ko not_active Ceased
- 1999-02-04 NZ NZ334065A patent/NZ334065A/en unknown
- 1999-02-04 CN CN99101764A patent/CN1228994A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| DE69932113D1 (de) | 2006-08-10 |
| CN1228994A (zh) | 1999-09-22 |
| NO990471L (no) | 1999-08-05 |
| KR19990072423A (ko) | 1999-09-27 |
| IL128329A (en) | 2005-08-31 |
| KR19990072406A (ko) | 1999-09-27 |
| AU713568B2 (en) | 1999-12-02 |
| HUP9900251A3 (en) | 2001-01-29 |
| CZ33799A3 (cs) | 1999-08-11 |
| NZ334065A (en) | 2000-06-23 |
| JP2000119193A (ja) | 2000-04-25 |
| DE69932113T2 (de) | 2007-01-25 |
| HU9900251D0 (en) | 1999-03-29 |
| KR100311565B1 (ko) | 2001-11-02 |
| AU1542699A (en) | 1999-08-26 |
| CA2260423A1 (en) | 1999-08-04 |
| NO990471D0 (no) | 1999-02-01 |
| CA2260423C (en) | 2006-06-20 |
| ATE331533T1 (de) | 2006-07-15 |
| SG66504A1 (en) | 2000-07-18 |
| JP3092706B2 (ja) | 2000-09-25 |
| IL128329A0 (en) | 2000-01-31 |
| HUP9900251A2 (hu) | 1999-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11160866B2 (en) | Biomaterials for delivery of blood extracts and methods of using same | |
| AU662024B2 (en) | The use of biomaterials for tissue repair | |
| EP1981556B1 (en) | Bone graft and scaffolding materials immobilized with type i collagen binding peptides | |
| CA2239775A1 (en) | Crosslinked polymer compositions and methods for their use | |
| MA26551A1 (fr) | Agonistes de prostaglandines nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
| JP2003525916A5 (cs) | ||
| CA2220555A1 (en) | Methods and compositions for healing and repair of connective tissue attachment | |
| DE69739169D1 (de) | Auf temperatur ansprechendes gel zur verzögerten freisetzung von proteinarzneistoffen | |
| MA26514A1 (fr) | Agonistes de prostaglandines, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
| ATE413415T1 (de) | Polymere enthaltend polysaccharide wie alginate oder modifizierte alginate | |
| CA2266645A1 (fr) | Copolymeres reticules a base de polymeres polycarboxyliques | |
| CA2445239A1 (en) | Drug delivery matrices to enhance wound healing | |
| WO1998022097A3 (en) | Controlled release matrix composition using polar polymer or monomer and poly(acrylic acid) blend | |
| FR2738151B1 (fr) | Antagonistes de l'activite oncogenique de la proteine mdm2, et leur utilisation dans le traitement des cancers | |
| BR9708906A (pt) | Processo para a preparação de pós polímeros redispersáveis em solução aquosa e de tamp es poliméricos pós poliméricos redispersáveis em solução aquosa utilização de pós poliméricos redispersáveis em solução aquosa e de composições tamponantes tamp es poliméricos e formulações cosméticas farmacêuticas ou para proteção de colhietas | |
| WO2009134054A2 (en) | Heparin-conjugated fibrin gel and method and kit for preparing the same | |
| MA26625A1 (fr) | Conjugue de proteine hedgehog a activite accrue, procede pour sa production, et son utilisation therapeutique | |
| MA26602A1 (fr) | Composition pharmaceutique de proteines hedgehog, procédé pour sa préparation, et son utilisation pour la libération de ces proteines sur les os et le cartilage. | |
| CA2243323A1 (fr) | Poudres redispersables dans l'eau de polymeres filmogenes prepares a partir de monomeres a insaturation ethylenique | |
| EP1806367A3 (en) | Polymers containing polysaccharides such as alginates or modified alginates | |
| EP1974754A1 (en) | Biomaterial for osteogenesis containing osteogenesis promoter and nanogel | |
| CA2225998A1 (en) | Gene preparations containing biocompatible material for sustained release in gene therapy | |
| Ayhan et al. | Functional PEG macromers for biomedical applications | |
| FR2786182B1 (fr) | Nouveaux derives d'acylguanidines, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant | |
| FR2747682B1 (fr) | Procede pour la preparation de poudres de polymere par polymerisation en suspension |